17-50114058-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_ModerateBP6_Moderate
The ENST00000330175.9(SAMD14):c.964C>A(p.Pro322Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000322 in 1,613,526 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P322A) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000330175.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SAMD14 | NM_001257359.2 | c.964C>A | p.Pro322Thr | missense_variant | 9/10 | ENST00000330175.9 | NP_001244288.1 | |
SAMD14 | NM_174920.4 | c.1048C>A | p.Pro350Thr | missense_variant | 10/11 | NP_777580.1 | ||
SAMD14 | XM_017024322.3 | c.1213C>A | p.Pro405Thr | missense_variant | 8/9 | XP_016879811.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SAMD14 | ENST00000330175.9 | c.964C>A | p.Pro322Thr | missense_variant | 9/10 | 1 | NM_001257359.2 | ENSP00000329144 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152162Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000440 AC: 11AN: 249804Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135460
GnomAD4 exome AF: 0.0000294 AC: 43AN: 1461364Hom.: 1 Cov.: 31 AF XY: 0.0000330 AC XY: 24AN XY: 727018
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152162Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74318
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 23, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at